Skip to main content

Advertisement

SpringerLink
Log in

Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy

  • Case Report
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To report on the use of intravitreal triamcinolone acetonide as treatment for nonarteritic anterior ischemic optic neuropathy (NAION).

Methods

The interventional clinical case series included three patients with acute NAION who received an intravitreal injection of about 20 mg triamcinolone acetonide.

Results

At the end of follow-up at 3 months, 3.5 months and at 5 months after the injection, visual acuity had changed from 0.10 at baseline to 0.20 in the first patient, from 0.50 to 0.20 in the second patient, and from 0.16 to 0.20 in the third patient. One eye developed triamcinolone-induced ocular hypertension which was treated by topical antiglaucomatous medication.

Conclusions

The clinical courses of all three patients presented suggest that an intravitreal high-dosage injection of triamcinolone acetonide may not be markedly effective in increasing visual acuity after acute NAION.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Al-Haddad CE, Jurdi FA, Bashshur ZF (2004) Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol 137:1151–1153

    Article  PubMed  CAS  Google Scholar 

  2. Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC (1984) Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 91:1334–1337

    PubMed  CAS  Google Scholar 

  3. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS (1997) Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123:212–217

    PubMed  CAS  Google Scholar 

  4. Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766–780

    PubMed  CAS  Google Scholar 

  5. Jonas JB, Kreissig I, Söfker A, Degenring RF (2003) Intravitreal injection of triamcinolone acetonide for diabetic macular edema. Arch Ophthalmol 121:57–61

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany

    Jost B. Jonas, Ulrich H. Spandau, Bjoern Harder & Gangolf Sauder

Authors
  1. Jost B. Jonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich H. Spandau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bjoern Harder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gangolf Sauder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jost B. Jonas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jonas, J.B., Spandau, U.H., Harder, B. et al. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefe's Arch Clin Exp Ophthalmol 245, 749–750 (2007). https://doi.org/10.1007/s00417-006-0332-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-006-0332-4

Keywords

Search

Navigation